Edmund Maclaughlin, MD
Rheumatology · Easton, MDNPI 1912966268
Payments from drug & device makers
Across 981 payments — averaging $417.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$351K
- Lilly USA, LLC$32K
- Sobi, Inc$16K
- Invivyd Inc$2K
- Johnson & Johnson$2K
- AbbVie$1K
- plus $5K from 32 others
What the payments were for
- Consulting fees$8,8632%
- Speaking & faculty fees$292,23371%
- Grants$2400%
- Travel & lodging$86,37821%
- Food & beverage$21,6655%
- Education$2680%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 504 | $350,852 |
| Lilly USA, LLC | 125 | $32,125 |
| Sobi, Inc | 35 | $16,035 |
| Invivyd Inc | 1 | $2,173 |
| Johnson & Johnson | 41 | $1,918 |
| AbbVie | 50 | $1,384 |
| UCB, Inc. | 40 | $807 |
| Mallinckrodt Hospital Products Inc. | 14 | $494 |
| Pfizer | 26 | $490 |
| Novartis | 20 | $413 |
| E.r. Squibb & Sons, L.L.C. | 26 | $373 |
| Sanofi | 11 | $347 |
| Radius Health, Inc. | 12 | $293 |
| GSK | 14 | $233 |
| Pacira Therapeutics, Inc. | 7 | $191 |
| Janssen Scientific Affairs, LLC | 2 | $184 |
| AstraZeneca | 5 | $146 |
| Actelion Pharmaceuticals US, Inc. | 1 | $124 |
| Gilead | 1 | $116 |
| Bristol Myers Squibb | 7 | $112 |
| Shire North American Group Inc | 1 | $105 |
| Aurinia Pharma U.S., Inc. | 4 | $91 |
| Medexus Pharma, Inc. | 6 | $80 |
| Mallinckrodt Enterprises LLC | 4 | $79 |
| Boehringer Ingelheim | 3 | $67 |
| Ultragenyx Pharmaceutical Inc. | 3 | $60 |
| Sanofi-aventis U.S. LLC | 1 | $53 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Organon | 5 | $46 |
| Cardinal Health Inc | 1 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Genentech USA, Inc. | 2 | $32 |
| Octapharma USA, Inc. | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $20 |
| Tersera Therapeutics LLC | 1 | $20 |
| Alvogen Inc | 1 | $16 |
| Eisai Inc. | 1 | $14 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$409,646 in reported general payments places this provider in the 90th percentile of 173 rheumatology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Easton
- Elizabeth ClaytonEaston$244K
- Naila AhmadEaston$15K
- Steven KleinHagerstown$3.4M
- Herbert BarafWheaton$1.4M
- Paul DemarcoWheaton$1.4M
- Thomas Grader BeckBaltimore$1.2M
- Michelle PetriBaltimore$1.1M
- Laura HummersBaltimore$1M
- Alan MatsumotoWheaton$720K
- Evan SiegelRockville$624K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.